| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2082830 | Drug Discovery Today: Therapeutic Strategies | 2013 | 6 Pages |
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by intra- and extracellular deposits of aggregated proteins in the brains of affected individuals. Transgenic mice have been developed to show some of these characteristic histopathological hallmarks of AD in the brain. The availability of transgenic mice with different transgene combinations has given new insights into the pathology of AD and has suggested new approaches and routes to testing disease-modifying treatments.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Christian Czech, Fiona Grueninger,